Legal Representation
Attorney
Kevan L. Morgan
USPTO Deadlines
Next Deadline
895 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-11)
Due Date
January 11, 2028
Grace Period Ends
July 11, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
47 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 11, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Oct 26, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 26, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 6, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 20, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 13, 2021 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
Jun 16, 2021 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
Jun 15, 2021 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
Apr 22, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
Apr 22, 2021 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
Apr 21, 2021 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
Mar 18, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 17, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 17, 2021 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Aug 25, 2020 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
Aug 6, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 17, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 17, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 17, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 17, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 17, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 17, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Jan 17, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jan 6, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 6, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 6, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 6, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 6, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 6, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Jan 6, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Dec 6, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Dec 6, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Dec 6, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Dec 6, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Dec 6, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Dec 6, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Dec 6, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Nov 7, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 7, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 9, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 9, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
May 9, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 20, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 4, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
(Based on 44(e)) Measuring, detecting and monitoring instruments, measuring, detecting and monitoring devices, and measuring, detecting and monitoring regulators, for preparing, processing and evaluating diagnostic samples, for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Sensors and detectors, in particular UV fluorescence and chemiluminescence detectors for preparing, processing and evaluating diagnostic samples; Apparatus for recording, transmission and reproduction of diagnostic data, sound and images, in particular cameras, microscopes, photometers, microplate photometers, enzyme-linked immunosorbent assay readers, photomultipliers, and microplate readers; (Based on Use in Commerce) Recorded software, downloadable software, and software recorded on media, in particular laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer
First Use Anywhere:
Nov 20, 2018
First Use in Commerce:
Nov 20, 2018
Class 042
(Based on 44(e)) Scientific services and research, in particular scientific services for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Industrial analysis in the nature of analysis of industrial and medical fluids and reagents; Scientific research services, in particular research services for evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Design and development of computer hardware and software, in particular laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; (Based on Use in Commerce) Providing on-line non-downloadable software, namely, laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer
First Use Anywhere:
Nov 20, 2018
First Use in Commerce:
Nov 20, 2018
Additional Information
Pseudo Mark
EURO LAB OFFICE
Classification
International Classes
009
042